GPT and COVID-19: In COVID-19, the prognostic value of abnormal liver function tests is not well defined, but some studies state that abnormal liver function tests, particularly elevated AST, total bilirubin and ALT, are associated with increased disease severity [1,2,10,20,22,29,36–38], whereas other studies report that there is no association between disease severity and progression [40,41].